DK2142570T3 - Anti-EpCam-antistof og anvendelser deraf - Google Patents

Anti-EpCam-antistof og anvendelser deraf

Info

Publication number
DK2142570T3
DK2142570T3 DK08759374.5T DK08759374T DK2142570T3 DK 2142570 T3 DK2142570 T3 DK 2142570T3 DK 08759374 T DK08759374 T DK 08759374T DK 2142570 T3 DK2142570 T3 DK 2142570T3
Authority
DK
Denmark
Prior art keywords
epcam antibody
therapeutic
designated
high affinity
shows high
Prior art date
Application number
DK08759374.5T
Other languages
English (en)
Inventor
Anna Maria Anastasi
Fiorella Petronzelli
Santis Rita De
Saverio Alberti
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Application granted granted Critical
Publication of DK2142570T3 publication Critical patent/DK2142570T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/77—Internalization into the cell
DK08759374.5T 2007-04-04 2008-04-02 Anti-EpCam-antistof og anvendelser deraf DK2142570T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07105628 2007-04-04
PCT/EP2008/053913 WO2008122551A2 (en) 2007-04-04 2008-04-02 Anti-epcam antibody and uses thereof

Publications (1)

Publication Number Publication Date
DK2142570T3 true DK2142570T3 (da) 2011-10-03

Family

ID=38458122

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08759374.5T DK2142570T3 (da) 2007-04-04 2008-04-02 Anti-EpCam-antistof og anvendelser deraf

Country Status (21)

Country Link
US (1) US8318911B2 (da)
EP (1) EP2142570B1 (da)
JP (1) JP5631733B2 (da)
KR (1) KR101683884B1 (da)
CN (1) CN101970497B (da)
AT (1) ATE512988T1 (da)
AU (1) AU2008235566B2 (da)
BR (1) BRPI0810096A8 (da)
CA (1) CA2682296C (da)
CY (1) CY1111819T1 (da)
DK (1) DK2142570T3 (da)
EA (1) EA023679B1 (da)
ES (1) ES2367675T3 (da)
HR (1) HRP20110620T1 (da)
IL (1) IL201196A0 (da)
MX (1) MX2009010444A (da)
PL (1) PL2142570T3 (da)
PT (1) PT2142570E (da)
RS (1) RS52040B (da)
SI (1) SI2142570T1 (da)
WO (1) WO2008122551A2 (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1585974B1 (en) 2003-01-24 2013-02-27 University of Utah Methods of predicting mortality risk by determining telomere length
CN107083444B (zh) 2008-12-22 2023-03-14 犹他大学研究基金会 单色多重定量pcr
GB0909904D0 (en) * 2009-06-09 2009-07-22 Affitech As Product
CN103561771B (zh) 2011-03-17 2019-01-04 伯明翰大学 重新定向的免疫治疗
CN107315086B (zh) * 2011-06-29 2019-09-10 中央研究院 使用表面涂层对生物物质的捕获、纯化和释放
WO2013131001A1 (en) * 2012-03-02 2013-09-06 Academia Sinica ANTI-EPITHELIAL CELL ADHESION MOLECULE (EpCAM) ANTIBODIES AND METHODS OF USE THEREOF
US9494500B2 (en) 2012-10-29 2016-11-15 Academia Sinica Collection and concentration system for biologic substance of interest and use thereof
ES2762860T3 (es) 2013-05-22 2020-05-26 Telomere Diagnostics Inc Medidas de abundancia de telómeros cortos
US10495644B2 (en) 2014-04-01 2019-12-03 Academia Sinica Methods and systems for cancer diagnosis and prognosis
TW201612308A (en) 2014-08-26 2016-04-01 Academia Sinica Collector architecture layout design
JP2018501799A (ja) 2014-12-30 2018-01-25 テロメア ダイアグノスティクス インコーポレイテッド マルチプレックス定量的ｐｃｒ
WO2017023704A1 (en) * 2015-07-31 2017-02-09 Sutro Biopharma, Inc. ANTI-EpCAM ANTIBODIES, COMPOSITIONS COMPRISING ANTI-EpCAM ANTIBODIES AND METHODS OF MAKING AND USING ANTI-EpCAM ANTIBODIES
US10107726B2 (en) 2016-03-16 2018-10-23 Cellmax, Ltd. Collection of suspended cells using a transferable membrane
CN109195990A (zh) * 2016-03-30 2019-01-11 Musc研究发展基金会 通过靶向糖蛋白a重复优势蛋白(garp)治疗和诊断癌症以及单独或联合提供有效免疫疗法的方法
AU2017301826A1 (en) 2016-07-26 2019-03-14 Tessa Therapeutics Ltd. Chimeric antigen receptor
WO2020018964A1 (en) 2018-07-20 2020-01-23 Fred Hutchinson Cancer Research Center Compositions and methods for controlled expression of antigen-specific receptors
US11702482B2 (en) 2018-12-17 2023-07-18 Revitope Limited Twin immune cell engager
TW202039582A (zh) * 2019-04-22 2020-11-01 大陸商江蘇恆瑞醫藥股份有限公司 抗ＥｐＣＡＭ抗體及其應用
WO2020252095A1 (en) 2019-06-11 2020-12-17 Bioatla, Inc. Conditionally active anti-epcam antibodies, antibody fragments, their immunoconjugates and uses thereof
CN110950959B (zh) * 2020-02-25 2020-07-03 和铂医药(上海)有限责任公司 靶向EpCAM的抗体及其制备和应用
CN112094350B (zh) * 2020-06-01 2024-01-05 普众发现医药科技(上海)有限公司 可应用于肿瘤细胞捕获的小鼠抗细胞表面糖蛋白cd326的单克隆抗体

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675187A (en) 1983-05-16 1987-06-23 Bristol-Myers Company BBM-1675, a new antibiotic complex
US5525338A (en) 1992-08-21 1996-06-11 Immunomedics, Inc. Detection and therapy of lesions with biotin/avidin conjugates
IT1245748B (it) 1990-12-21 1994-10-14 Mini Ricerca Scient Tecnolog Preparazione includente anticorpi monoclonali biotinilati, avidina e biotina, per la diagnosi di affezioni tumorali e suo impiego
US5578287A (en) 1992-06-09 1996-11-26 Neorx Corporation Three-step pretargeting methods using improved biotin-active agent
JP3427871B2 (ja) 1996-06-24 2003-07-22 戸田工業株式会社 コバルト被着型針状磁性酸化鉄粒子粉末
ITRM20010079A1 (it) 2001-02-16 2002-08-16 Sigma Tau Ind Farmaceuti Amminoderivati della biotina e loro coniugati con chelanti macrociclici.
US20050180979A1 (en) * 2004-02-13 2005-08-18 Micromet Ag Anti-EpCAM immunoglobulins
US7435804B2 (en) * 2004-10-19 2008-10-14 Phage Biotechnology, Inc. Method for obtaining single chain antibodies to human interferon α2b

Also Published As

Publication number Publication date
BRPI0810096A8 (pt) 2017-12-26
IL201196A0 (en) 2010-05-17
MX2009010444A (es) 2009-10-20
WO2008122551A2 (en) 2008-10-16
KR20100016237A (ko) 2010-02-12
AU2008235566B2 (en) 2013-06-06
CY1111819T1 (el) 2015-10-07
CA2682296A1 (en) 2008-10-16
EP2142570A2 (en) 2010-01-13
WO2008122551A9 (en) 2009-02-05
PL2142570T3 (pl) 2011-11-30
ATE512988T1 (de) 2011-07-15
RS52040B (en) 2012-04-30
ES2367675T3 (es) 2011-11-07
US8318911B2 (en) 2012-11-27
WO2008122551A3 (en) 2008-12-04
CN101970497B (zh) 2017-05-10
JP2010523096A (ja) 2010-07-15
CN101970497A (zh) 2011-02-09
US20100092491A1 (en) 2010-04-15
BRPI0810096A2 (pt) 2014-10-21
EP2142570B1 (en) 2011-06-15
EA200970923A1 (ru) 2010-04-30
KR101683884B1 (ko) 2016-12-07
CA2682296C (en) 2017-02-28
SI2142570T1 (sl) 2012-01-31
JP5631733B2 (ja) 2014-11-26
EA023679B1 (ru) 2016-06-30
PT2142570E (pt) 2011-09-13
HRP20110620T1 (hr) 2011-09-30
AU2008235566A1 (en) 2008-10-16

Similar Documents

Publication Publication Date Title
DK2142570T3 (da) Anti-EpCam-antistof og anvendelser deraf
CY1123400T1 (el) Ανθρωπινα anti-il-23 αντισωματα, συνθεσεις, μεθοδοι και χρησεις
CY1118760T1 (el) Τροποποιημενα αντισωματα εναντι il-23
UA113712C2 (xx) Антитіло до fap і способи його застосування
CY1117236T1 (el) Μονοκλωνικα αντισωματα εναντι γλυπικανης-3
WO2016210365A3 (en) Constructs targeting ny-eso-1 peptide/mhc complexes and uses thereof
EA201201533A1 (ru) Prlr-специфическое антитело и его применения
EA200900040A1 (ru) Молекулы антител, которые связываются с человеческим il-17
TW200510459A (en) RG1 antibodies and uses thereof
MX2009008926A (es) Aplicaciones terapeuticas de activacion de celulas que presentan antigeno humano por medio de detectina a-1.
CU24058B1 (es) Antagonistas de pcsk9
TW200732349A (en) Anti-OX40L antibodies and methods using same
NO20083397L (no) Anti-EphB4-antistoffer og fremgangsmater for anvendelse av disse
AR058325A1 (es) Anticuerpos anti mn y metodos para su utilizacion
EA201100868A1 (ru) Противоопухолевые комбинации, содержащие антитела, специфически распознающие cd38, и цитарабин
EA200801174A1 (ru) Антитела-миметики glp-2, полипептиды, композиции, способы и применения
BRPI0416141B8 (pt) anticorpo anti-cd52 modificado, composição farmacêutica, vetores de expressão, e método para preparar uma imunoglobulina
EP2542581A4 (en) SPECIFIC APOLIPOPROTEIN ANTIBODY AND METHODS OF USING SAME
MX2019011624A (es) Metodos y composiciones para la reduccion de la inmunogenicidad.
DK1572087T3 (da) Antistoffer med cancerantigen TMEFF2 og anvendelser deraf
DE602006007967D1 (de) Gegen das gemeinsame epitop von mutierten p53 gerichtete humane synthetische einzelkettenantikörper und anwendungen davon
CR10143A (es) Antígenos de ácido des-n-acetil-siálico, anticuerpos para los mismos y métodos de uso en la terapia del cáncer
TW200738751A (en) Anti-EphrinB2 antibodies and methods using same
BR112018073660A2 (pt) anticorpos anti-fator ix pádua
WO2017015634A3 (en) Constructs targeting psa peptide/mhc complexes and uses thereof